IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 199 filers reported holding IMMUNOGEN INC in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,532,078 | -18.2% | 663,647 | -2.7% | 0.03% | -17.5% |
| Q2 2023 | $12,873,623 | +2102.3% | 682,227 | +348.2% | 0.04% | +1900.0% |
| Q1 2023 | $584,559 | -45.4% | 152,229 | -29.4% | 0.00% | -50.0% |
| Q4 2022 | $1,070,179 | +10.8% | 215,762 | +44.0% | 0.00% | 0.0% |
| Q4 2020 | $966,000 | +61.3% | 149,795 | -10.0% | 0.00% | +100.0% |
| Q3 2020 | $599,000 | -22.9% | 166,495 | -1.4% | 0.00% | -50.0% |
| Q2 2020 | $777,000 | +5.4% | 168,895 | -21.8% | 0.00% | -20.0% |
| Q1 2020 | $737,000 | -36.5% | 215,995 | -5.1% | 0.01% | +25.0% |
| Q4 2019 | $1,161,000 | +105.5% | 227,495 | -2.5% | 0.00% | +100.0% |
| Q3 2019 | $565,000 | -41.5% | 233,395 | -47.6% | 0.00% | -33.3% |
| Q2 2019 | $966,000 | -20.2% | 445,055 | -0.4% | 0.00% | -40.0% |
| Q1 2019 | $1,211,000 | -44.0% | 446,955 | -0.8% | 0.01% | -50.0% |
| Q4 2018 | $2,163,000 | -36.4% | 450,555 | +25.4% | 0.01% | -16.7% |
| Q3 2018 | $3,402,000 | +1432.4% | 359,200 | +1474.9% | 0.01% | +1100.0% |
| Q2 2018 | $222,000 | – | 22,808 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |